Colonoscopic surveillance – a cost-effective method to prevent hereditary and familial colorectal cancer

References

• Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–932.
   PubMed Web of Science ®Google Scholar
• Stoffel EM, Kastrinos F. Familial colorectal cancer, beyond Lynch syndrome. Clin Gastroenterol Hepatol. 2014;12:1059–1068.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute: Genetics of Colorectal Cancer. 2017. [cited17.02.06]; Available from: https://www.cancer.gov/types/colorectal/hp/colorectal-genetics-pdq#section/all.
   Google Scholar
• Chubb D, Broderick P, Frampton M, et al. Genetic Diagnosis of High-Penetrance Susceptibility for Colorectal Cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. JCO. 2015;33:426–432.
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–689.
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739–750.
   PubMed Web of Science ®Google Scholar
• Dove-Edwin I, Sasieni P, Adams J, et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005;331:1047
   PubMed Web of Science ®Google Scholar
• Hennink SD, van der Meulen-de Jong AE, Wolterbeek R, et al. Randomized comparison of surveillance intervals in familial colorectal cancer. J Clin Oncol. 2015;33:4188–4193.
   PubMed Web of Science ®Google Scholar
• Sjostrom O, Lindholm L, Tavelin B, et al. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer. Fam Cancer. 2016;15:543–551.
   PubMed Web of Science ®Google Scholar
• Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829–834.
   PubMed Web of Science ®Google Scholar
• Olsen KR, Bojesen SE, Gerdes AM, et al. Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer. J Inter Tech Health Care. 2007;23:89–95.
   PubMed Web of Science ®Google Scholar
• Ouakrim DA, Boussioutas A, Lockett T, et al. Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer. 2014;14:261.
   PubMed Web of Science ®Google Scholar
• Vasen HF, van Ballegooijen M, Buskens E, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998;82:1632–1637.
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Wilschut J, Boer R, et al. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs. Am J Gastroenterol. 2010;105:1861–1869.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Ferrandez A, Lanas A. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev. 2010;19:2765–2776.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Hälsoekonomiskt underlag, Nationella riktlinjer för tjock- och ändtarmscancer 2014. [Health economic evidence, National guidelines for colorectal cancer 2014]. 2014. [cited 16.06.01]; Available from: https://www.socialstyrelsen.se/SiteCollectionDocuments/nr-cancer-halsoekonomiskt-underlag-tjock-andtarmscancer.pdf. Swedish.
   Google Scholar
• Burström K. Hälsorelaterad livskvalitet i Stockholms län 2002. [Health related quality of life in Stockholm 2002]. Stockholm: Stockholms läns landsting; 2006.
   Google Scholar
• Statistics Sweden: 2016. [cited16.01.01]; Available from: http://www.scb.se/sv_
   Google Scholar
• Kodeda K, Nathanaelsson L, Jung B, et al. Population-based data from the Swedish Colon Cancer Registry. Br J Surg. 2013;100:1100–1107.
   PubMed Web of Science ®Google Scholar
• Ness RM, Holmes AM, Klein R, et al. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol. 1999;94:1650–1657.
   PubMed Web of Science ®Google Scholar
• van Hees F, Saini SD, Lansdorp-Vogelaar I, et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology. 2015;149:1425–37.
   PubMed Web of Science ®Google Scholar
• Niv Y, Bogolavski I, Ilani S, et al. Impact of colonoscopy on quality of life. Eur J Gastroenterol Hepatol. 2012;24:781–786.
   PubMed Web of Science ®Google Scholar
• Kapidzic A, Korfage IJ, van Dam L, et al. Quality of life in participants of a CRC screening program. Br J Cancer. 2012;107:1295–1301.
   PubMed Web of Science ®Google Scholar
• Balmana J, Sanz J, Bonfill X, et al. Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Int J Cancer. 2004;112:647–652.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen: Värdet av populationsbaserad screening för bröstcancer – hälsoekonomisk analys [Screening for breast cancer - health economic analysis]; 2013. [cited 16.09.01]; Available from: https://www.socialstyrelsen.se/SiteCollectionDocuments/nr-screening-brostcancer-halsoekonomi.pdf. Swedish.
   Google Scholar
• Socialstyrelsen: Tjock- och ändtarmscancer, screening med test av blod i avföringen [Colorectal cancer, screening with faecal blood tests]; 2013. [cited16.09.01]; Available from: http://www.socialstyrelsen.se/SiteCollectionDocuments/screening-tjockandtarmscancer-halsoekonomi.pdf. Swedish.
   Google Scholar
• Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.
   PubMed Web of Science ®Google Scholar
• Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer. 2012;106:805–816.
   PubMed Web of Science ®Google Scholar
• Møller, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66:464–472.
   PubMed Web of Science ®Google Scholar
• Forsberg AM, Hagel E, Jaramillo E, et al. Predicting outcome in colonoscopic high-risk surveillance. Anticancer Res. 2015;35:4813–4819.
   PubMed Web of Science ®Google Scholar